Guest editorial
| dc.contributor.author | Van Niekerk, Andre | |
| dc.date.accessioned | 2025-12-03T05:25:24Z | |
| dc.date.available | 2025-12-03T05:25:24Z | |
| dc.date.issued | 2025-03 | |
| dc.description.abstract | Many short courses (bursts) of oral corticosteroids (OCS) are commonly prescribed for indicated and non-indicated conditions. These bursts are perceived to be safe and are usually given by prescription for less than 14 days at a time. The global corticosteroid market was USD 5.7 billion in 2023, and with a projected annual growth rate of 4.6% across all regions, reflects its widespread use. Published data of OCS use in South Africa are difficult to find, yet parents of children attending a clinic for immune deficiencies frequently report repetitive prescriptions. | |
| dc.description.department | Paediatrics and Child Health | |
| dc.description.department | Immunology | |
| dc.description.librarian | am2025 | |
| dc.description.sdg | SDG-03: Good health and well-being | |
| dc.description.uri | https://journals.co.za/journal/caci | |
| dc.identifier.citation | Van Niekerk, A. 2025, 'Guest editorial', Current Opinion in Allergy and Clinical Immunology, vol. 38, no. 1, pp. 4, doi : 10.10520/ejc-caci-v38-n1-a1. | |
| dc.identifier.issn | 1609-3607 (print) | |
| dc.identifier.other | 10.10520/ejc-caci-v38-n1-a1 | |
| dc.identifier.uri | http://hdl.handle.net/2263/107058 | |
| dc.language.iso | en | |
| dc.publisher | Allergy Society of South Africa | |
| dc.rights | Allergy Society of South Africa | |
| dc.subject | Immune deficiencies | |
| dc.subject | Corticosteroids | |
| dc.subject | Oral corticosteroids (OCS) | |
| dc.subject | South Africa (SA) | |
| dc.subject | Editorial | |
| dc.title | Guest editorial | |
| dc.type | Article |